We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USCT
1251
DELISTED
Roth CH Acquisition Co. Class A Ordinary Shares
USCT
$4.39M 0.01%
425,913
-695,497
-62% -$7.12M
SVNAW
1252
CALL
DELISTED
7 Acquisition Corp Warrant
SVNAW
$4.38M 0.01%
424,999
LVAC
1253
DELISTED
LAVA Medtech Acquisition Corp. Class A Common Stock
LVAC
$4.37M 0.01%
425,490
CRGY icon
1254
Crescent Energy
CRGY
$3.46B
$4.36M 0.01%
363,415
-128,471
-26% -$1.77M
NFNT.WS
1255
CALL
DELISTED
Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFNT.WS
$4.36M 0.01%
424,999
ADALW
1256
CALL
DELISTED
Anthemis Digital Acquisitions I Corp Warrant
ADALW
$4.35M 0.01%
419,960
HHLA.WS
1257
CALL
DELISTED
HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HHLA.WS
$4.35M 0.01%
430,336
-103,088
-19% -$6.61K
TWLO icon
1258
Twilio
TWLO
$29.5B
$4.35M 0.01%
+88,826
New +$5.06M
JUN.WS
1259
CALL
DELISTED
Juniper II Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
JUN.WS
$4.34M 0.01%
426,300
PAR icon
1260
PAR Technology
PAR
$682M
$4.33M 0.01%
165,981
+67,054
+68% +$1.73M
EWC icon
1261
iShares MSCI Canada ETF
EWC
$6.13B
$4.32M 0.01%
+132,100
New +$4.38M
NHICW
1262
CALL
DELISTED
NewHold Investment Corp. II Warrant
NHICW
$4.32M 0.01%
428,748
MEKA
1263
DELISTED
MELI Kaszek Pioneer Corp Class A Ordinary Shares
MEKA
$4.31M 0.01%
432,750
CRWD icon
1264
CrowdStrike
CRWD
$183B
$4.31M 0.01%
163,628
-3,229,008
-95% -$111M
SHCO
1265
DELISTED
Soho House & Co
SHCO
$4.31M 0.01%
1,151,177
+844,326
+275% +$3.47M
PEP icon
1266
PUT
PepsiCo
PEP
$191B
$4.3M 0.01%
+23,800
New +$4.25M
ENTFW
1267
CALL
DELISTED
Enterprise 4.0 Technology Acquisition Corp. Warrant
ENTFW
$4.29M 0.01%
417,378
TRIS.WS
1268
CALL
DELISTED
Tristar Acquisition I Corp. Redeemable Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
TRIS.WS
$4.29M 0.01%
419,532
KAIRW
1269
CALL
DELISTED
Kairos Acquisition Corp. Warrant
KAIRW
$4.28M 0.01%
424,996
PLMR icon
1270
Palomar
PLMR
$3.73B
$4.28M 0.01%
94,760
+60,635
+178% +$4.13M
JMAC
1271
DELISTED
Maxpro Capital Acquisition Corp. Class A Common Stock
JMAC
$4.27M 0.01%
411,065
VTLE
1272
DELISTED
Vital Energy
VTLE
$4.27M 0.01%
83,021
-65,172
-44% -$4.02M
HPQ icon
1273
PUT
HP
HPQ
$24.3B
$4.27M 0.01%
158,800
+1,300
+0.8% +$36K
S icon
1274
SentinelOne
S
$6.22B
$4.26M 0.01%
292,086
+167,299
+134% +$3.1M
TA
1275
DELISTED
TravelCenters of America LLC
TA
$4.26M 0.01%
95,166
+10,105
+12% +$523K

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.